Pfizer Inc (NYSE:PFE)

Friday’s trading has closed, but PFE is being traded in the after-hours session. After-Hours quote »
29.11
Data as of 4:03pm ET
 +0.51 / +1.78%
Today’s Change
27.51
Today|||52-Week Range
32.96
-4.96%
Year-to-Date
Markets End Hectic Week On Positive Note
6:28pm / Benzinga
Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?
Oct 20 / MotleyFool.com
Will Pfizer (PFE) Disappoint This Earnings Season? - Analyst Blog
5:57pm / Zacks.com
M&A deal failure at highest since 2008
Oct 19 / FT.com
Pfizer Announces Share Buyback, Shares Pop Up
2:51pm / Benzinga
How to Buy Stocks That Can Make Your Kids Rich
Oct 19 / MotleyFool.com
3 Stocks Reiterated As A Buy: PFE, AIG, WFC
2:33pm / TheStreet.com
Could This Game-Changing Drug Deliver $10 Billion in Sales Within Its First Year?
Oct 18 / MotleyFool.com
Bristol-Myers Beats on Q3 Earnings, Maintains Guidance - Analyst Blog
1:35pm / Zacks.com
UPDATE: FDA Has Approved New Labeling on Pfizer's Embeda
Oct 17 / Benzinga
Bellwether UPS rises on ecommerce hopes
1:27pm / FT.com
Pfizer's AstraZeneca pursuit knocked by Shire deal collapse
Oct 17 / FT.com
Shire and AstraZeneca show standalone strength
1:11pm / FT.com
3 Small-Cap Biotech Stocks to Buy if the Market Crashes
Oct 15 / MotleyFool.com
Pfizer (PFE) $11B Stock Repurchase Plan May End AstraZeneca (AZN) Bid
12:14pm / TheStreet.com
AbbVie drops B#32bn bombshell on Shire
Oct 15 / FT.com
Five Things to Know Now: Amazon Tumbles
10:37am / TheStreet.com
Johnson & Johnson and Bristol-Myers Squibbbs New Collaboration Just the Tip of the Ic...
Oct 15 / MotleyFool.com
Glaxo Gains on Q3 Earnings Beat and Restructuring Plans - Analyst Blog
10:15am / Zacks.com
FDA Sends Mixed Message On Safety of Pfizer inc.'s Chantix
Oct 15 / MotleyFool.com
Overnight Futures Fail To Ramp As Algos Focus On New York's First Ever Ebola Case
8:11am / Investing Channel
Shire: Inversions row should not (hop)scotch tax competition
Oct 15 / FT.com
Frontrunning: October 23
Oct 23 / Investing Channel
Pfizer's Breast Cancer Candidate Gets Priority Review - Analyst Blog
Oct 14 / Zacks.com
Drug ETFs Attractive Buys On Pullback
Oct 22 / Benzinga
A Quick Look at Pfizer Inc.'s Drug Development Pipeline
Oct 14 / MotleyFool.com
Key Takeaways From GlaxoSmithKline's Third-Quarter Earnings
Oct 22 / MotleyFool.com
Can Dividend Stock GlaxoSmithKline plc Bounce Back?
Oct 14 / MotleyFool.com
GSK's Witty fights back with strong message to shareholders
Oct 22 / FT.com
Where Will Celgene Corporation Stock Be a Year From Now?
Oct 14 / MotleyFool.com
Third Point's Daniel Loeb Tells Amgen it's Time to Break up
Oct 22 / TheStreet.com
Ireland's Double Irish faces its demise
Oct 14 / FT.com
Amgen: splitting hairs
Oct 22 / FT.com
Steris makes UK tax leap with $1.9bn Synergy inversion deal
Oct 13 / FT.com
Technology, tax and talent in Dublin
Oct 21 / FT.com
Will Johnson & Johnson Beat Earnings on Pharma Sales? - Analyst Blog
Oct 13 / Zacks.com
Exxon Mobil Corporation, The Procter & Gamble Company, Pfizer Inc.: The Case For Blue...
Oct 21 / Investing Channel
The Next Biotech Buyout Stock
Oct 10 / MotleyFool.com
MannKind Corporation's Investors Shouldn't Dance Around This Issue
Oct 21 / MotleyFool.com
Breaking up is the latest Wall Street craze
Oct 06 / CNNMoney.com
Amgen Sues Sanofi and Regeneron over PCSK9 Candidate - Analyst Blog
Oct 20 / Zacks.com
BD agrees to buy CareFusion for $12.2bn
Oct 05 / FT.com
M&A Deals Fail At Highest Rate Since 2008
Oct 20 / Investing Channel
Cork brushes off Apple tax claims
Oct 03 / FT.com
Why Pfizer (PFE) Stock Remains a 'Buy' at TheStreet
Oct 20 / TheStreet.com
Salix pulls deal amid US tax crackdown
Oct 03 / FT.com
3 Stocks Reiterated As A Buy: PFE, MU, CELG
Oct 20 / TheStreet.com
Top 10 companies lobbying Washington
Oct 01 / CNNMoney.com
Dow Jones (DJIA) Today: Pfizer (PFE) Lower
Oct 20 / TheStreet.com
Multibillion cross-border deals make a return after five years
Sep 30 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.